Prevalence and risk factors of chronic kidney disease: A population study in the Tibetan population

Nephrology Dialysis Transplantation

Volumn 26, Issue 5, 2011, Pages 1592-1599

  Chen, Wei ^a   Liu, Qinghua ^a   Wang, Hui ^a   Chen, Weiqing ^a   Johnson, Richard J ^b   Dong, Xiuqing ^a   Li, Haiying ^c   Ba, Sang ^d   Tan, Jiaqing ^a   Luo, Ning ^a   Liu, Tao ^a   He, Huijuan ^a   Yu, Xueqing ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c People's Hospital   (China)

^d People's Hospital of Dangxiong County   (China)

Author keywords

chronic kidney disease; epidemiology; high altitude; Tibet

Indexed keywords

ALBUMIN; URIC ACID;

ADULT; ALBUMINURIA; ALTITUDE; ARTICLE; CHINA; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; GLOMERULUS FILTRATION RATE; HEMATOCRIT; HEMATURIA; HUMAN; HYPERTENSION; HYPERURICEMIA; INTERVIEW; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ADULT; ALBUMINURIA; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMATURIA; HUMANS; HYPERTENSION; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; TIBET;

EID: 79955601775     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq608     Document Type: Article

References (31)

1. Chen W, Chen W, Wang H et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant 2009; 24: 1205-1212
2. Ma YC, Zuo L, Chen JH et al. Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. JAm Soc Nephrol 2006; 17: 2937-2944 (Pubitemid 44484685)
3. Chobanian AV, Bakris GL, Black HR et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-2572 (Pubitemid 37430158)
4. The IDF consensus worldwide definition of the metabolic syndrome http://www.idf.org/webdata/docs/IDF-Metasyndrome-definition.pdf (12 August 2009, date last accessed)
5. Zhang L, Zhang P, Wang F et al. Prevalence and factors associated with CKD: a population study from Beijing. Am JKidney Dis 2008; 51: 373-384 (Pubitemid 351273470)
6. Plata R, Cornejo A, Arratia C et al. Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective rando-mised trial. Lancet 2002; 359: 663-666 (Pubitemid 34203766)
7. Jefferson JA, Escudero E, Hurtado ME et al. Hyperuricemia, hyper-tension, and proteinuria associated with high-altitude polycythemia. Am JKidney Dis 2002; 39: 1135-1142 (Pubitemid 34591927)
8. Jefferson JA, Escudero E, Hurtado ME et al. Excessive erythrocyto-sis, chronic mountain sickness, and serum cobalt levels. Lancet 2002; 359: 407-408 (Pubitemid 34158954)
9. Jefferson JA, Simoni J, Escudero E et al. Increased oxidative stress following acute and chronic high altitude exposure. High Alt Med Biol 2004; 5: 61-69 (Pubitemid 38455805)
10. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence ofkidney dam-age in Australian adults: the Aus Diab Kidney Study. JAm Soc Ne-phrol 2003; 14: S131-S138 (Pubitemid 36750508)
11. Vaziri ND, Wang ZQ. Sustained systemic arterial hypertension induced by extended hypobaric hypoxia. Kidney Int 1996; 49: 1457-1463 (Pubitemid 26166421)
12. Mazzali M, Jefferson JA, Ni Z et al. Microvascular and tubulointer-stitial injury associated with chronic hypoxia-induced hypertension. Kidney Int 2003; 63: 2088-2093 (Pubitemid 36605819)
13. Epstein FH, Agmon Y, Brezis M. Physiology ofrenal hypoxia. Ann NYAcad Sci 1994; 15: 72-81
14. Fine LG, Orphanides C, Norman JT Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl 1998; 65: S74-S78 (Pubitemid 28204569)
15. Inatomi J, Matsuoka K, Fujimaru R et al. Mechanisms of development and progression of cyanotic nephropathy. Pediatr Nephrol 2006; 21: 1440-1445 (Pubitemid 44283477)
16. Hayabuchi Y, Matsuoka S, Akita H et al. Hyperuricaemia in cyanotic congenital heart disease. Eur JPediatr 1993; 152: 873-876 (Pubitemid 23323001)
17. Faustinella F, Uzoh C, Sheikh-Hamad D et al. Glomerulomegaly and proteinuria in a patient with idiopathic pulmonary hypertension. JAm Soc Nephrol 1997; 8: 1966-1970 (Pubitemid 28185456)
18. Kang DH, Nakagawa T, Feng L et al. A role for uric acid in the pro-gression ofrenal disease. JAm Soc Nephrol 2002; 13: 2888-2897 (Pubitemid 35386908)
19. Nakagawa T, Mazzali M, Kang DH et al. Hyperuricemia causes glomerular hypertrophy in the rat Am J Nephrol 2003; 23: 2-7 (Pubitemid 35316757)
20. Mazzali M, Hughes J, Kim YG et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001; 38: 1101-1106 (Pubitemid 34252813)
21. Mazzali M, Kanellis J, Han L et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechan-ism. Am J Physiol Renal Physiol 2002; 282: F991-F997 (Pubitemid 34654464)
22. Sanchez-Lozada LG, Soto V, Tapia E et al. Role of oxidative stress in the renal abnormalities induced by experimental hyperuricemia. Am J Physiol Renal Physiol 2008; 295: F1134-F1141
23. Sanchez-Lozada LG, Tapia E, Avila-Casado C et al. Mild hyperuri-cemia induces glomerular hypertension in normal rats. Am J Physiol Renal Physiol 2002; 283: F1105-F1110 (Pubitemid 35192478)
24. Sanchez-Lozada LG, Tapia E, Lopez-Molina R et al. Effects of acute and chronic L-arginine treatment in experimental hyperuricemia. Am J Physiol Renal Physiol 2007; 292: F1238-F1244 (Pubitemid 46572443)
25. Sanchez-Lozada LG, Tapia E, Rodriguez-Iturbe B et al. Hemo-dynamics of hyperuricemia. Semin Nephrol 2005; 25: 19-24
26. Feig DI, Soletsky B, Johnson RJ. Effect of allopurinol on the blood pressure of adolescents with newly diagnosed essential hypertension. JAMA 2008; 300: 922-930
27. Siu YP, Leung KT, Tong MK et al. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level. Am JKidney Dis 2006; 47: 51-59 (Pubitemid 41828266)
28. Corry DB, Eslami P, Yamamoto K et al. Uric acid stimulates vascular smooth muscle cell proliferation and oxidative stress via the vascular renin-angiotensin system. J Hypertens 2008; 26: 269-275
29. Sun SF. Epidemiology of hypertension on the Tibetan Plateau. Hum Biol 1986; 58: 507-515
30. Hu YS, Yao CH, Wang WZ et al. Survey on the prevalence of hyper-tension in different ethnic groups in China in 2002. Wei Sheng Yan Jiu 2006; 35: 573-575
31. Liu Y, Zhuoma C, Shan G et al. A1166C polymorphism of the angiotensin II type 1 receptor gene and essential hypertension in Han, Tibetan and Yi populations. Hypertens Res 2002; 25: 515-521